Carefully Selected News and Features About Metastatic Breast Cancer Research
Metastatic Trial Talk empowers you with knowledge about the latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
New ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
Click to learn about elacestrant (Orserdu™) as well as the Guardant360 blood test that identifies people likely to benefit from the...Read more
New Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for HR-positive, triple-negative, and other...Read more
ASCO Experts Update Guidance for Sacituzumab Govitecan (Trodelvy®) for HR+, HER2- MBC
Read for information on the FDA's expanded approval of Trodelvy® and ASCO's updated guidance on the use of this...Read more
FDA Approves Orserdu™ and Expands Approval of Trodelvy®
Read about the clinical trials that contributed to 2 recent approvals of MBC treatment...Read more
What are Non-Treatment Trials and Why are They Important?
Many clinical trials study ways to improve quality of life, manage side effects, and advance cancer research. Learn more...Read more
Black Wo(Men) Speak Symposium 2022
Click for an overview of information from the symposium highlighting the need for increased diversity in clinical...Read more
What to Know About MBC Treatment-Related Heart Problems
Some MBC treatments can cause or increase the risk of heart problems. Read more about research studying how to monitor and treat...Read more
SEARCH OUR SITE
for past articles or specific information.